Phencyclidine (PCP) & Amphetamine
Phencyclidine, commonly known as PCP or "angel dust," is a synthetic dissociative drug that alters sensory perceptions, mood, and cognition. Originally developed as an anesthetic, its medical use was discontinued due to its severe and unpredictable psychological effects. Today, it's known mostly for its use as a recreational drug, notorious for its potent and often dangerous effects.
PCP primarily exerts its effects through its action as a non-competitive antagonist of the N-methyl-D-aspartate (NMDA) receptor, which is a type of glutamate receptor in the brain. Glutamate is the primary excitatory neurotransmitter in the central nervous system, and its proper functioning is crucial for normal cognitive and neurological activity. PCP binds to the NMDA receptor and blocks the channel that allows ions like calcium to flow into the neuron. This blockade disrupts normal neural communication and leads to the drug's dissociative effects.
Beyond its impact on glutamate receptors, PCP also affects other neurotransmitter systems. It increases dopamine levels by inhibiting the dopamine transporters, which is likely responsible for some of its euphoric effects. It may also interact with sigma receptors, which can modulate the release of various neurotransmitters and contribute to hallucinations and other psychotomimetic effects.
The use of PCP can be particularly unpredictable and can lead to severe psychological reactions and dangerous behavior. Its dissociative effects can cause users to feel invulnerable, which might lead to accidental injuries or self-harm. Chronic use of PCP can lead to long-lasting cognitive deficits, memory loss, and emotional disturbances.
Amphetamine is a potent central nervous system (CNS) stimulant that affects the brain by enhancing certain types of neuronal activity. It is used therapeutically to treat attention deficit hyperactivity disorder (ADHD), narcolepsy, and certain cases of obesity. In recreational contexts, it is often used for its euphoric, energizing effects.
Amphetamine promotes the release of dopamine and norepinephrine from their storage vesicles in neurons. This increase in neurotransmitter levels in the synaptic cleft (the gap between neurons) enhances neurotransmission and stimulates activity in parts of the brain related to alertness, attention, and response to the environment.
Normally, neurotransmitters are reabsorbed by neurons through transporter proteins. Amphetamine inhibits these transporters, particularly the dopamine transporter (DAT) and the norepinephrine transporter (NET). This inhibition prevents the reuptake of dopamine and norepinephrine, allowing them to remain active in the synaptic cleft for longer periods, thereby amplifying their effects.
Amphetamine also induces a reverse transport of dopamine and norepinephrine, meaning it can reverse the normal direction of neurotransmitter transport. Instead of being taken up by neurons, neurotransmitters are pushed back into the synapse, further increasing their extracellular concentrations and enhancing their stimulatory effects on the CNS.
Combining Phencyclidine (PCP) and Amphetamine can lead to unpredictable and potentially severe effects. Each drug has distinct actions on the brain that can compound the risks when taken together:
- Neurotransmitter Systems Overload. PCP's inhibition of glutamate receptors and amphetamine's promotion of dopamine and norepinephrine release can lead to altered synaptic activities and neurochemical balances, potentially enhancing or muting the effects of one another. The combination may overly stimulate the CNS, creating conflicting signals within the brain's regulatory systems. This includes confusion, erratic behavior, extreme agitation, and potential psychosis.
- Increased Cardiovascular Stress: Both drugs increase heart rate and blood pressure, which can strain the cardiovascular system, leading to potential acute events like heart attack or stroke.
- Severe Psychiatric Symptoms: The combination can exacerbate or precipitate psychotic episodes, severe paranoia, and violent behavior.
- Neurotoxicity: Both drugs have potential neurotoxic effects that may be exacerbated when used in combination.
- High Overdose Risk: With this combination the risks of overdose and urgent states are increasing significantly.
Given these interactions, the combination of PCP and Amphetamine is considered highly dangerous and is generally advised against due to the severe, dangerous, and life-threatening risks involved.
All things considered, we recommend avoiding this combination under any conditions.
Last edited by a moderator: